Dr. Maha Hussain, MD, FACP, FASCO
Claim this profileNorthwestern University
Studies Prostate Cancer
Studies Bladder Cancer
6 reported clinical trials
14 drugs studied
Area of expertise
1Prostate Cancer
Stage IV
TP53 positive
TP53 negative
2Bladder Cancer
Stage IV
Stage III
Affiliated Hospitals
Clinical Trials Maha Hussain, MD, FACP, FASCO is currently running
Eribulin + Chemotherapy
for Bladder Cancer
This phase III trial compares the usual chemotherapy treatment to eribulin plus gemcitabine in treating patients with urothelial cancer that has spread from where it first started (primary site) to other places in the body (metastatic). Chemotherapy drugs, such as eribulin, gemcitabine, docetaxel, paclitaxel, and sacituzumab govitecan work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. This trial aims to see whether adding eribulin to standard of care chemotherapy may work better in treating patients with metastatic urothelial cancer.
Recruiting2 awards Phase 3
Radioactive Drug Therapy
for Prostate Cancer
This trial studies how well lutetium Lu 177 dotatate works in treating patients with a specific type of prostate cancer that has spread. The drug targets cancer cells and releases radiation to kill them. Lutetium-177 (Lu-177) PSMA therapy is a targeted treatment for advanced prostate cancer that has shown promising results.
Recruiting1 award Phase 216 criteria
More about Maha Hussain, MD, FACP, FASCO
Clinical Trial Related4 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Maha Hussain, MD, FACP, FASCO has experience with
- Abiraterone Acetate
- Olaparib
- Prednisone
- Enzalutamide
- LY2157299
- Pembrolizumab
Breakdown of trials Maha Hussain, MD, FACP, FASCO has run
Prostate Cancer
Bladder Cancer
Transitional Cell Carcinoma
Urothelial Carcinoma
Abnormal DNA Repair
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Maha Hussain, MD, FACP, FASCO specialize in?
Maha Hussain, MD, FACP, FASCO focuses on Prostate Cancer and Bladder Cancer. In particular, much of their work with Prostate Cancer has involved Stage IV patients, or patients who are TP53 positive.
Is Maha Hussain, MD, FACP, FASCO currently recruiting for clinical trials?
Yes, Maha Hussain, MD, FACP, FASCO is currently recruiting for 3 clinical trials in Chicago Illinois. If you're interested in participating, you should apply.
Are there any treatments that Maha Hussain, MD, FACP, FASCO has studied deeply?
Yes, Maha Hussain, MD, FACP, FASCO has studied treatments such as Abiraterone Acetate, Olaparib, Prednisone.
What is the best way to schedule an appointment with Maha Hussain, MD, FACP, FASCO?
Apply for one of the trials that Maha Hussain, MD, FACP, FASCO is conducting.
What is the office address of Maha Hussain, MD, FACP, FASCO?
The office of Maha Hussain, MD, FACP, FASCO is located at: Northwestern University, Chicago, Illinois 60611 United States. This is the address for their practice at the Northwestern University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.